Less Is More: Cost-Effective Psoriasis Management via Disease-Driven Dosing of IL-17/IL-23 Inhibitors. (PubMed, Dermatol Pract Concept) - Oct 11, 2026 - "DR was both clinically effective and cost-saving, maintaining disease control without major safety concerns. These findings support the implementation of DR strategies in routine clinical practice to enhance long-term sustainability while preserving therapeutic efficacy."
HEOR • Journal • Dermatology • Immunology • Psoriasis • IL17A • IL23A
|
|
Alessia Pisterna; Andrealuna Ucciero; Chiara Airoldi; Claudia Leporati; Edoardo Cammarata; Francesca Graziola; Franco Castelli; Gianluca Rossotto; Ginevra Pertusi; Jacopo Colombo; Lorenza Burzi; Luca Mastorino; Massimo Chiarpenello; Michela Ortoncelli; Paola Savoia; Paolo Dapavo; Paolo Pella; Pietro Quaglino; Rossana Tiberio; Simone Ribero; Veronica Arese
|